<DOC>
	<DOCNO>NCT00708799</DOCNO>
	<brief_summary>The purpose study determine whether macrolide treatment patient severe sepsis advantageous immunomodulatory clinical effect compare severe septic patient without macrolide therapy . Our main hypothesis macrolide use addition standard therapy severe septic patient advantageous immunomodulatory clinical effect compare patient severe sepsis treat macrolide .</brief_summary>
	<brief_title>Efficacy Macrolide Immunomodulation Severe Sepsis .</brief_title>
	<detailed_description>In recent study , significant effect macrolide antibiotic ( azithromycin ) immune response , unrelated anti-microbial property , appreciate . Clinical trial macrolides add -lactams bacteremic Streptococcus pneumoniae community-acquired pneumonia ( CAP ) consistently demonstrate absolute risk reduction mortality 15 % population . Several cytokine include tumor necrosis factor ( TNF ) interleukin ( IL ) -1 IL-8 generally proinflammatory IL-6 IL-10 , tend anti-inflammatory associate sepsis . TNF cytokine number reason think play central role pathogenesis sepsis septic shock . TNF concentration increase clinical experimental sepsis increase concentration especially persistence high concentration TNF sepsis associate decreased survival . Therefore , primary aim determine whether macrolide treatment patient severe sepsis advantageous immunomodulatory clinical effect compare severe septic patient without macrolide therapy . Our main hypothesis macrolide use addition standard therapy severe septic patient advantageous immunomodulatory clinical effect compare patient severe sepsis treat macrolide .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
	<criteria>1 . Subject , legal representative , give write informed consent . 2 . 18 year age old . 3 . SIRS define two : Temperature &gt; 38o C &lt; 36oC Heart rate &gt; 90 beats/min Respiratory rate &gt; 20 breaths/min PaCO2 &lt; 32mmHg White blood cell count &gt; 12.000/mm3 ; &lt; 4000/mm3 ; &gt; 10 % immature ( band ) form . 4 . Presence suspect proven infection . Patients suspected infection must evidence infection , white blood cell normally sterile body fluid , perforate viscus , chest xray consistent pneumonia associate purulent sputum production , clinical syndrome associate high probability infection ( example , purpura fulminans ascend cholangitis ) . 5 . Presence one sepsisassociated organ failure . The onset first sepsisassociated organ failure must occur within 48hour period immediately precede initiation study drug infusion . A patient must organ failure attributable sepsis episode . The organ failure must newly develop explain underlying disease process effect concomitant therapy . Cardiovascular : An arterial systolic blood pressure ( SBP ) 90 mm Hg mean arterial pressure ( MAP ) 70 mm Hg least 1 hour despite adequate fluid resuscitation , adequate intravascular volume status , need vasopressor maintain SBP 90 mm Hg MAP 70 mm Hg . Renal : Average urine output &lt; 0.5 mL/kg/h 1 hour despite adequate fluid resuscitation Respiratory : Evidence acute pulmonary dysfunction PaO2/FiO2 300 , clinical exam pulmonary capillary wedge pressure suggestive volume overload . If pneumonia suspect site infection , patient must PaO2/FiO2 200 . Hematology : Platelet count &lt; 80,000/mm3 50 % decrease platelet count high value record last 3 day . Unexplained metabolic acidosis : Defined ( 1 ) pH 7.30 base deficit 5.0 mEq/L ( 2 ) plasma lactate level &gt; 1.5 time upper limit normal . Adequate fluid resuscitation adequate intravascular volume define either pulmonary arterial wedge pressure 12 mm Hg central venous pressure 8 mm Hg . Vasopressors define dopamine 5 g/kg/min dose norepinephrine , epinephrine , phenylephrine . Dobutamine consider vasopressor . 1 . Macrolide therapy indicate clinical condition . If randomization , treat physician determines macrolide indicate alternative antibiotic appropriate , patient exclude trial . However , one dose azithromycin give treat physician decide stop , azithromycin might administer . 2 . Known allergy macrolides . 3 . Prolonged QT syndrome medication increase risk QT prolongation . 4 . Pregnant lactating . Immunosuppression define : 1 . Chemotherapy within last 30 day , 2 . Leukemia lymphoma remission , 3 . Solid organ bone marrow/stem cell transplant , 4 . Human Immunodeficiency Virus infection CD4 count &lt; 200 cells/mm3 , 5 . Chronic corticosteroid use equivalent &gt; 10 mg prednisone per day , 6 . Patient family decision limit ICU care .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>